Serum kynurenine and neopterin concentrations were determined in patients with chronic mesangioproliferative glomerulonephritis with normal renal function and in patients with chronic renal failure. Significantly increased kynurenine and neopterin levels have been observed in 28% of mesangioproliferative glomerulonephritis patients. In vitro, interferon-y induces the formation of neopterin in human monocytes/macrophages. Also the degradation of tryptophan via the kynurenine pathway is induced by interferon-yo Our data show increased kynurenine and neopterin concentrations in serum in the case of mesangioproliferative glomerulonephritis. There was a positive correlation between serum kynurenine and neopterin levels. The same association between kynurenine and neopterin have been found in patients with chronic renal failure . At the end stage of renal disease, elevated levels of kynurenine and neopterin corresponded to the decrease of renal functions. In 59% of patients with mesangioproliferative glomerulonephritis, we detected also pyridoxal-5-phosphate deficiency concomitant with the increase of serum concentration of kynurenine. L-tryptophan peroral loading test could be useful for differentiation the both causes of hyperkynureninemia .
Introduction
The etiology of chronic glomerulonephritis is unknown. The pathogenesis of chronic glomerulonephritis seems to involve autoimmunological mechanisms (1) . The possible underlying factors could be bacterial (A, P Streptococcus haemolyticus;
Haemophylus parainfluenzae) or viral infections (2) . These factors are closely associated with stimulation of cell-mediated immunity, endogenous release of interferon-y and indoleamine (2,3)-dioxygenase activation which degrades tryptophan via the kynurenine pathway (3, 4, 5) . Kynurenine is § Address for correspondence: Dr. A. Martinsons, Kuldigas 23-4 Riga, LV 1007 Latvia the key metabolite of the tryptophan-nicotinic acid pathway.
In our previous work we have shown that hyperkynureninemia can partICIpate in the development of mesangioproliferative glomerulonephritis by impairing renal endotheliocytes and epitheliocytes (6 ) . In vitro, interferon-y induces also neopterin biosynthesis. Increased neopterin levels were observed in clinical pathologies which involved activation of cell-mediated immunity, e.g. dilated cardiomyopathy (7) . Increased kynurenine formation, reduced degradation and elimination may cause kynurenine accumulation in the organism. Kynurenine can be split by three enzyme systems: kynureninase, kynurenine hydroxylase and kynureninaminotransferase. Two of them, kynureninase and kynurenine-aminotransferase, are pyridoxal-S-phosphate (P-S-P) dependent enzymes (8) . Therefore, hyperkynureninemia could develop also in the case of P-S-P deficiency in the organism. A decreased kynurenine elimination could take place in the case of chronic renal failure.
The measurement of serum kynurenine and neopterin levels before and after peroral Ltryptophan load could be useful III the differentiation the immune stimulation of the organism from the P-S-P deficiency.
Patients and methods
10 healthy individuals, 36 patients with mesangioproliferative glomerulonephritis (MesPG) with normal renal functions (7 with high proteinuria> 2 g/24 hand 29 with moderate proteinuria < 2 g/24 h) and 7 patients with chronic renal failure (glomerular filtration rate < 40 ml/min) have been examined. The patients were from the Centre of Nephrology in Riga, Latvia. The diagnosis of MesPG was based on kidney biopsy with microscopical examination of biopsy materiaL Serum concentrations of L-tryptophan, kynurenine and neopterin have been determined after fasting and 3 hours after L-tryptophan oral load ( 30 mg/ kg body weight).
The amount of L-tryptophan in serum was determined by the method of Spies and Chambers (9) . The concentration of kynurenine in serum was determined by the method of Joseph and Risby ( 10 ) . Neopterin concentrations were measured by radioimmunoassay ( 11). Renal functions have been controlled by the concentration of serum creatinine.
Groups were compared using Students t-test.
In case of p < O.OS, the difference was considered to be statistically significant (12) .
Results
In the case of MesPG with proteinuria> 2 g/24 h we found decreased levels of serum tryptophan before and 3 hours after L-tryptophan load, the se rum concentrations of kynurenine and neopterin did not differ from the control group (Table 1 ). In patients with MesPG with proteinuria < 2 g/24 h we found an increased level of serum kynurenine and neopterin compared with healthy controls. In this group of patients we have established 4 variations of the changes in serum kynurenine and neopterin concentrations ( Table 2) : Group I=normal concentrations of serum kynurenine and neopterin ( n=4; 13%); group II=increased levels of serum kynurenine before and 3 hours after L-tryptophan load, normal neopterin concentrations (n= 13; 46%); group III=increased levels of serum kynurenine only 3 hours after L -tryptophan load, normal amount of serum neopterin (n=4; 13%); and group IV =increased levels of seru m kynurenine before L-tryptophan load; increased levels of serum neopterin before and 3 hours after L-tryptophan load (n=8; 28%). In the last group we have determined a positive correlation (rs= 0.6S4) between the serum concentrations of kynurenine and neopterin before L-tryptophan load (Fig. 1) .
In the patients with chronic renal insufficiency we obtained increased levels of serum kynurenine and neopterin before and after L-tryptophan load; the serum concentrations of tryptophan were decreased before and after L-tryptophan load. Table 1 . Serum tryptophan, kynurenine and neopterin concentrations in the control group, in patients with mesangioproliferative glomerulonephritis (MesPG) with proteinuria < 2 g/24 hand> 2 g/24 h, and in patients with chronic renal insufficiency (CRI) with glomerular filtration rate (GFR) 20-40 ml/min before and 3 hours after L-tryptophan peroral loading 30 mg/ kg body weight (Mean values±S.D. are shown) 
Discussion
H yperkynureninemia can develop in the case of P -5 -P deficiency, by the immune stimulation of the organism or limited elimination of kynure nine with urine (chronic renal failure ) ( 3, 4, 5 ) . Ltryptophan peroral loading test is an acceptable test for the diagnosis o f the P-S-P deficiency ( 13 ) . In the case of overt P -5-P deficiency there w ill be increased amounts of kynurenine before and after L-tryptophan load. We have found an overt P-S-P deficiency in 46% of patients with MesPG with proteinuria < 2 g/ 24 h. The early stage of P-S-P deficiency can be detected only by the application of L-uyptophan peroral loading test; increased amounts of kynurenine will appear within 3 hours after the load, if compared with increased accumulation of ky nurenine obtained in healthy individuals. 13% of o ur patients presented w ith The possible m echanisms for P-S-P d e ficiency in chronic glomerulonephritis are not completely elucidated. It is known that the activation of P-5-P takes place in the kidney (14) . There is the possibility that in the case of glomerulonephritis this process could be impaired. In the patients with chronic renal failure there are also increased levels of serum kynurenine both before and after L -tryptophan load. In these cases the elevated amounts of ky nurenine correspond to the deterioration of renal function. There are also data about P-5-P deficiency in chronic renal failure ( 15 ) . Possible mechanisms could be the loss of p yridox ine during dialysis, d ecreased amounts of pyridoxin e in diet, the ure mic toxins inhibiting pyridoxine , or a disturbed activation of pyridoxine in the kidney ( 16, 17) .
Increased neopt e rin concentrations in human serum indicate cellular immune activation and endogenous release of interferon-yo Neopterin formation is strongly induced in human monocytes / macrophages on stimulation with interfe ron-y ( 18) . In parallel, degradation of tryptophan is stimulated in a variety of human cells and cell lines due to activatio n of indoleamine (2,3)-dioxygenase by interferon-y leading to the formation of kynurenine ( 3, 4, 5 ) . In this situation there will be increased le\'els o f serum kynurenine and neopte rin.
Significant associations between exogenous and endogeno u s interferon-y induced neopterin formation and tryptophan degradation with concomitant for m a tion of k y nurenine are obseryed in a \'ariety of clinical situations like immunostimulato ry treatment of cancer patients, patients with human immunodeficiency virus infection, \\'ith Ly me neuroborreliosis and dilated cardiomyopathy ( 7, 19) . We have found increased concentrations of neopterin and kynurenine in 28% of MesPG patients with proteinuria < 2 g/24 h. In this group the immune stimulation of the organism (cell-mediated immunity) is the cause of hyperkynureninemia and hyperneopterinemia. The pathogenetic basis of chronic glomerulonephritis includes bacterial and viral infections and autoimmune phenomena with the release of interferon -"{ (1,2) .
In our previous work we show that hyperkynureninemia can participate in the development of MesPG by impairing renal endotheliocytes and epitheliocytes ( 6 ) . Cytokines like interferon -? and interleukin-1 could induce the proliferation of mesangial cells per se (20, 24) . The proliferation of mesangial cells and the transformation to fibroblasts could lead to nephrosclerosis and chronic renal insufficiency (23) .
In the case of chronic renal insufficiency the increased level of neopterin corresponds to an increase of serum creatinine (25) . In all our patients we have found decreased levels of serum tryptophan. In the case of high proteinuria there is a loss of tryptophan with urine. In the case of P-5-P deficiency there could be disturbed reabsorption of aminoacids from the gastrointestinal tract (21). There are also some possible explanations for chronic renal insufficiency which maybe associated with altered reabsorption from the gastrointestinal tract (toxic effect of uremic toxins, also a P-5-P deficiency in the organism, refs. 16, 17) . There are reports that in the case of terminal renal failure there is an increased amount of free tryptophan in serum, because of the defective connection to albumin (21, 22) .
The formation of kynurenine occurs in liver, but the degradation takes place in kidneys (26) . It is possible that in renal diseases and chronic renal failure the conversion of kynurenine is less efficient and could lead to an accumulation of kynurenine in serum.
Our data suggests several possible mechanisms underlying hyperkynureninemia in MesPG patients. L-tryptophan peroral loading test could be useful for the differential diagnosis of the origin of hyperkynureninemia differentiating P-5-P deficiency from kynurenine overproduction due to cell-mediated immune stimulation.
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